Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine
Sponsor: University of Virginia
Collaborators: National Cancer Institute (NCI)